Evidence map›Paper›PMID 24587343›Full record

ArticlePloS one2014

An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.

Krista M Pettee, Kaitlyn M Dvorak, Andrea L Nestor-Kalinoski, Kathryn M Eisenmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Krista M PetteeDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, Ohio, United States of America.
Kaitlyn M DvorakDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, Ohio, United States of America.
Andrea L Nestor-KalinoskiDepartment of Surgery, University of Toledo Health Science Campus, Toledo, Ohio, United States of America.
Kathryn M EisenmannDepartment of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, Ohio, United States of America.
University of Toledo · US

Funding

Mechanisms Driving Cortical Cytoskeleton Dynamics in Cancer Cell InvasionR01CA151632 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI EISENMANN, KATHRYN M · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA151632NCI NIH HHS R01CA151632
6 · The paper itself

Abstract

Multi-cellular spheroids are enriched in ascites of epithelial ovarian cancer (OvCa) patients. They represent an invasive and chemoresistant cellular population fundamental to metastatic dissemination. The molecular mechanisms triggering single cell invasive egress from spheroids remain enigmatic. mDia formins are Rho GTPase effectors that are key regulators of F-actin cytoskeletal dynamics. We hypothesized that mDia2-driven F-actin dynamics promote single cell invasive transitions in clinically relevant three-dimensional (3D) OvCa spheroids. The current study is a dissection of the contribution of the F-actin assembly factor mDia2 formin in invasive transitions and using a clinically relevant ovarian cancer spheroid model. We show that RhoA-directed mDia2 activity is required for tight spheroid organization, and enrichment of mDia2 in the invasive cellular protrusions of collagen-embedded OVCA429 spheroids. Depleting mDia2 in ES-2 spheroids enhanced invasive dissemination of single amoeboid-shaped cells. This contrasts with spheroids treated with control siRNA, where a mesenchymal invasion program predominated. Inhibition of another RhoA effector, ROCK, had no impact on ES-2 spheroid formation but dramatically inhibited spheroid invasion through induction of a highly elongated morphology. Concurrent inhibition of ROCK and mDia2 blocked single cell invasion from ES-2 spheroids more effectively than inhibition of either protein alone, indicating that invasive egress of amoeboid cells from mDia2-depleted spheroids is ROCK-dependent. Our findings indicate that multiple GTPase effectors must be suppressed in order to fully block invasive egress from ovarian cancer spheroids. Furthermore, tightly regulated interplay between ROCK and mDia2 signaling pathways dictates the invasive capacities and the type of invasion program utilized by motile spheroid-derived ovarian cancer cells. As loss of the gene encoding mDia2, DRF3, has been linked to cancer progression and metastasis, our results set the stage for understanding molecular mechanisms involved in mDia2-dependent egress of invasive cells from primary epithelial tumors.

Indexed as

Gene Expression Regulation, NeoplasticActin CytoskeletonCarcinoma, Ovarian EpithelialCarrier ProteinsCell Line, TumorCell MovementFemaleForminsHumansNeoplasms, Glandular and EpithelialOvarian NeoplasmsrhoA GTP-Binding Proteinrho-Associated KinasesRNA, Small InterferingSignal TransductionSpheroids, CellularCarrier ProteinsDIAPH2 protein, humanForminsrhoA GTP-Binding ProteinRHOA protein, humanrho-Associated KinasesRNA, Small Interfering

Identifiers

PMID24587343
PMCPMC3938721
OpenAlexW2027795380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.